BCL-2, topoisomerase IIα, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy

PURPOSE: The aim of this retrospective study was to investigate the effect of B cell lymphoma 2 (BCL-2) expression on disease-free survival (DFS) in 172 early breast cancer (BC) patients treated with anthracycline-based adjuvant chemotherapy. We have reanalysed follow-up data in these patient groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228164/
https://www.ncbi.nlm.nih.gov/pubmed/25005788
http://dx.doi.org/10.1007/s00432-014-1770-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228164/
https://www.ncbi.nlm.nih.gov/pubmed/25005788
http://dx.doi.org/10.1007/s00432-014-1770-8

Ejemplares similares